Orient Bio, a bio-infrastructure company, is launching a Cambodian primate CRO (non-clinical trust) – 매일경제

TOPMost ReadLanguageChange fontAAAAShareOrient Bio, a bio-infrastructure company, is launching a Cambodian primate CRO (non-clinical trust) business in response to a surge in global demand for experimental animals and a shortage of Chinese primates.According to the industry on the 9th, demand for non-clinical trials has increased due to the recent expansion of advanced biopharmaceutical development, while the price of crab monkeys for research has risen sharply. Accordingly, Orient Bio stabilized the supply of rodents, beagle dogs, and SPF rabbits through the nation’s largest experimental animal production center, while signing an exclusive business right contract with Orient Cam, a Cambodian primate production base, in July.The company plans to actively respond to the R&D needs of global pharmaceutical and bio companies by combining Orientkam’s production infrastructure and its know-how. Through this, the plan is to become a global preclinical bio-infrastructure company by using domestic experimental animal supply and overseas non-clinical testing projects as the two pillars.Reporter Lee Sang-gyu3 Hours ago3 Hours ago15 Hours ago12 Hours ago16 Hours ago1 Hour ago16 Hours ago15 Hours ago11 Hours ago22 Hours ago※ This article was translated using AI technology for reader convenience. Maeil Business(MK) provides these translations “as they are” and makes no warranties of any kind, either explicitly or implicitly, regarding accuracy, reliability and marketability, suitability for a particular purpose, etc. of translation. Please be informed that the content provided may not be translated accurately due to limitations in machine translation before using this service. Copyright (c) Maekyung AX. All rights reserved. Unauthorized reproduction, redistribution, or use for AI training is prohibited. source